"The changing paradigm": TAVR for low-risk patients approved by the FDA
J Card Surg
.
2020 Jan;35(1):5-7.
doi: 10.1111/jocs.14336.
Epub 2019 Nov 25.
Authors
Camilo A Gomez
1
,
Joao Braghiroli
1
,
Eduardo de Marchena
2
Affiliations
1
Jackson Memorial Hospital, Miller School of Medicine and Health System, University of Miami, Coral Gables, Florida.
2
Miller School of Medicine and Health System, Division of Cardiovascular Diseases, University of Miami, Coral Gables, Florida.
PMID:
31765011
DOI:
10.1111/jocs.14336
No abstract available
Keywords:
FDA; LOW RISK; SAVR; TAVR; TRIAL.
Publication types
Editorial
MeSH terms
Aortic Valve Stenosis / surgery*
Calcinosis / surgery*
Humans
Risk Factors
Transcatheter Aortic Valve Replacement*
Treatment Outcome